Quick Answer
Nasus Pharma Ltd reported Operating Income of -$4.90 million for fiscal year 2025.
Nasus Pharma Ltd Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$4.90M | -354.9% |
| 2024 | -$1.08M | +6.0% |
| 2023 | -$1.15M | — |
- Nasus Pharma Ltd showed a decrease of -354.9% in Operating Income compared to the prior fiscal year.
- Over the 2023–2025 period, Nasus Pharma Ltd’s operating income has declined by 327.6% (from -$1.15 million to -$4.90 million).
- The most recent figure is from Nasus Pharma Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: